Update on Surveillance Guidelines in Emerging Wilms Tumor Predisposition Syndromes

Area of Science:

• Pediatric Oncology
• Cancer Genetics
• Genomic Medicine

Background:

• Wilms tumor is frequently linked to genetic predisposition syndromes.
• Previous surveillance guidelines were published in 2017.
• Recent research has identified new genes associated with Wilms tumor risk.

Purpose of the Study:

• To update surveillance guidelines for Wilms tumor predisposition.
• To incorporate newly identified genes and risk estimates.
• To address emerging clinical scenarios in Wilms tumor predisposition.

Main Methods:

• Review of recently published evidence and risk estimates.
• Analysis of genetic variants associated with Wilms tumor.
• Discussion of clinical scenarios like familial Wilms tumor and mosaicism.

Main Results:

• Identified new genes with recurrent pathogenic variants increasing Wilms tumor risk.
• Provided updated risk estimates for these newly described genes.
• Discussed surveillance strategies for patients with familial Wilms tumor, bilateral tumors, and 11p15.5 mosaicism.

Conclusions:

• Harmonized updated surveillance recommendations for Wilms tumor predisposition.
• Emphasized the importance of considering emerging genetic factors and clinical scenarios.
• Aimed to guide healthcare professionals in managing patients at risk for Wilms tumor.